Cinven announces Partner promotions


Cinven today announces the promotion of three individuals to Partner with effect from 1 January 2021.

The three promotions to Partner are:

Sarah Verity-Thomas, Partner

Sarah is a member of the Investor Relations team and leads Cinven’s Client Services function on behalf of its Limited Partners. She has been involved in a number of fund and capital raisings, including the Fourth, Fifth, Sixth and Seventh Cinven Funds. She is a member of Cinven’s ESG Steering Group and is actively involved in driving the firm’s diversity & inclusion agenda. Sarah joined Cinven in 2005.

Matthew Norton, Partner

Matthew is a member of the Investment team, focussed on the healthcare sector. He has been involved in a number of transactions, including Envirotainer, LGC, Medpace, Sebia, STADA and Labco and Synlab (merged under the Synlab brand). Matthew joined Cinven in 2010.

Paul Vega, Partner

Paul Vega is a member of the Portfolio team, based in the London office. He has been involved in a number of investments, including TK Elevator, Viridium Group and PPF. Paul joined Cinven in 2019, following six years with Amcor Group in Zurich, where he held several executive roles, most recently as Vice President of the Healthcare business in EMEA and Head of Group Strategy.

Commenting on these promotions, Stuart McAlpine, Managing Partner of Cinven Partners LLP, said:

“We are delighted to announce these three promotions to Partner, which reflect Sarah, Matthew and Paul’s enormous hard work, dedication and considerable talents.

“These promotions further emphasise the breadth and depth within Cinven across all of our teams, and highlight our continued commitment to nurturing our own talent from within the firm, creating career pathways into Partnership positions.”

Categories: Personalia

Q announces appointment of Mauricio Arellano as Chief Executive Officer


Q, a global leader in outsourced medical manufacturing and silicone technologies for critical products including medical devices, electrical connector seals and insulators, announces the appointment of Mauricio Arellano as Chief Executive Officer. Mauricio follows Thomas J. Hook, who will remain involved with Q as a non-executive Director and is assuming the role of Chief Executive Officer of SaniSure, another 3i-owned life sciences business.

Mauricio has been with Q since 2018 and most recently served as the company’s Chief Operating Officer. He is a seasoned executive with a proven ability to grow global businesses efficiently and profitably and has a long tenure in the medical devices industry. Prior to Q, Mauricio was President of the Medical Division of Spectrum Plastics Group, a leading extrusion, injection molding, bioresorbables and assembly Medical Device outsourcing company with 16 plants and over 2,000 employees.

Prior to Spectrum, Mauricio held several executive leadership positions at Integer Holdings, including President of its Medical Division and EVP of Global Operations with responsibility for 30 manufacturing sites and over 9,000 employees. Before Integer, Mauricio held various operational management positions at Tyco Healthcare (now Medtronic) and Sony Electronics.

Richard Relyea, Partner at 3i, commented: “We are delighted to appoint Mauricio as CEO. Mauricio brings a wealth of operational and leadership experience. Throughout 2020, he played an increasingly pivotal role overseeing all aspects of our QSR and QMD operating units and has demonstrated tremendous results in leading our key growth and performance initiatives. We are confident in his ability to successfully lead Q into the future.

We would also like to extend our appreciation and gratitude to Tom for his contributions as CEO of Q. Over the past four years, Tom has successfully led the business through considerable transformation and positioned it for continued long-term success.”

Mauricio said: “As I reflect on the significant accomplishments Q has made over recent years, the strength of our organization and the opportunities that lie ahead, I could not be more proud of the business or more enthusiastic about its future. Q has truly differentiated capabilities and is a leader in our rapidly growing and exciting market segments. I believe we are on track to deliver significant value creation over the next several years, and I am humbled at the opportunity to lead the business. I look forward to working with all Q associates to realize the full potential of Q in the coming years through diligent execution and a focus on strong, strategic growth.”

Q comprises QMD™, which manufactures a broad range of high-performance, single-use devices as well as precision components and subassemblies, specializing in silicone and other elastomers; and QSR™, a global leader in turnkey custom molded, precision elastomeric components designed to safeguard harsh environment connectivity.


Categories: Personalia

Senior Investment Director Chris Bischoff leaves Kinnevik

No Comments

Kinnevik AB (publ) (“Kinnevik”) today announced that Senior Investment Director Chris Bischoff has decided to leave Kinnevik to take up a role as a Managing Director at General Catalyst. Chris will continue to represent Kinnevik on selected company boards.

Chris Bischoff joined Kinnevik in 2013 and during his time with Kinnevik has focused on the international investment activities, including leading the investments within Kinnevik’s successful healthcare portfolio, supported the formation of a strong sector focused investment team and leading the London office. Chris will leave Kinnevik during the second quarter, but he will continue to represent Kinnevik on selected company boards. Kinnevik has partnered with General Catalyst on multiples investments including Livongo and Cityblock and will continue to seek out opportunities to collaborate on new deals across sectors.

Kinnevik CEO Georgi Ganev commented: “I would like to thank Chris for his tremendous contribution to value-creation in Kinnevik, and for having been a great and trusted colleague and thought partner. I wish him all the best in his new role, and I look forward to continuing to develop our relationship with General Catalyst and our joint investee companies.”

Chris Bischoff commented: “I am thankful and proud for having been part of Kinnevik’s exciting and successful transition into a leading European growth investor. Looking ahead, Kinnevik is in a stronger position than ever to continue the journey and I look forward to staying in close touch in my new role.”

For further information, visit or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50

Kinnevik is a sector-focused investment company with an entrepreneurial spirit. Our purpose is to make people’s lives better by providing more and better choice. In partnership with talented founders and management teams we build challenger businesses that use disruptive technology to address material, everyday needs. As active owners, we believe in delivering both shareholder and social value by building long-term sustainable businesses that contribute positively to society. We invest in Europe, with a focus on the Nordics, the US, and selectively in other markets. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.

Categories: Personalia

Vaaka Partners strengthens team with new Partner and new Associate

Friday 29.01.2021

Vaaka Partners strengthens its investment team with two new recruits both starting in February. Mr Jarkko Murtoaro has been invited to join the team as Partner after 13 years at EQT. Mr Jesper Kontinen joins the team as Associate with prior experience from Goldman Sachs and McKinsey & Company.

Jarkko Murtoaro is well-known to the Vaaka team from his role at EQT, leading the Nordic pet care specialist Musti Group’s value creation towards its successful IPO. Vaaka Partners sold the majority stake of Musti Group to EQT 6 years ago but retained a minority shareholding during EQT’s ownership. Jarkko’s background includes investment banking with Citigroup in London before joining EQT in September 2007. During his time at EQT, Jarkko worked both in the Helsinki and Stockholm offices, and his latest position was a Managing Director. Jarkko is starting at Vaaka Partners as a Partner on February 1st.

Jarkko comments why he chose to join the firm: “Vaaka has a strong team and a great culture. I am excited to be joining the company and look forward to working with my new colleagues and the management teams of Vaaka companies.”

Jesper Kontinen has a Master of Science degree from the Aalto University Finance programme. Vaaka Partners became familiar to Jesper through our long-standing internship program in the spring of 2018. Thereafter, Jesper moved to London to join Goldman Sachs’ Investment Banking Division and in 2019 relocated back to Finland for a position at McKinsey & Company. Jesper is starting at Vaaka Partners as an Associate on February 1st.

“We are warmly welcoming Jarkko and Jesper to the team. Not only are they brilliant professionals, but also very nice persons and colleagues to collaborate with – an excellent culture fit”, says Juha Peltola, Managing Partner.

For more information

Juha Peltola, Managing Partner
+358 50 514 8401

Categories: Personalia

Michael Chia Joins Siris as Principal – Investor Relations


New York, January 6, 2021 – Siris, a leading private equity firm focused on investing and driving value creation in technology and telecommunications companies, today announced that Michael Chia has joined the firm as Principal – Investor Relations.  As a member of Siris’ Investor Relations team, Mr. Chia will help manage the firm’s relationships with its limited partners and prospective investors.  Mr. Chia most recently served as Principal at Adams Street Partners.

Mr. Chia brings more than a decade of experience helping investment firms develop and execute investor relations and business development strategies.  He will leverage his experience building relationships to help optimize Siris’ investor relations strategy.  At Adams Street Partners, Mr. Chia supported capital raising activities for the firm across private equity, venture capital, and private credit strategies.

Frank Baker, Co-Founder of Siris, commented, “Michael brings significant experience to Siris.  He is an accomplished professional with a proven track record of developing and maintaining strong investor relationships and enhancing investor relations strategies, and he will be a valuable addition to our Investor Relations team.”

Mr. Chia said, “I am excited to join Siris as the firm continues to enhance its operations and deepen investor relationships.  I look forward to collaborating with the rest of the Siris team to further build out the firm’s investor relations capabilities, as well as working closely with the firm’s limited partners as Siris pursues investment opportunities in the technology and telecommunications sectors.”

Prior to joining Adams Street Partners in 2014, Mr. Chia served as a Manager at Casey, Quirk & Associates, developing growth and business development strategies for investment managers.  Earlier in his career, Mr. Chia was a consultant at Deloitte, where he worked with clients to develop and implement operational and technological transformations.

Mr. Chia has been a Chartered Financial Analyst (CFA) Charterholder since 2017 and is a member of CFA Society San Francisco.  He is also a member of the Professional Council of Shriver Center on Poverty Law.  Mr. Chia holds a Bachelor of Arts in Economics from the University of Michigan.

 About Siris

Siris is a leading private equity firm that invests primarily in mature technology and telecommunications companies with mission-critical products and services, facing industry changes or other significant transitions. Siris’ development of proprietary research to identify opportunities and its extensive collaboration with its Executive Partners are integral to its approach. Siris’ Executive Partners are experienced senior operating executives that actively participate in key aspects of the transaction lifecycle to help identify opportunities and drive strategic and operational value. Siris is based in New York and Silicon Valley and has raised nearly $6 billion in cumulative capital commitments.

Media Contacts

Dana Gorman or Blair Hennessy
Abernathy MacGregor
1-212-371-5999 /

Categories: Personalia

Gryphon Investors Hires John Schumacher as a Partner

Gryphon Investors

San Francisco, CA – January 19, 2021 —


Gryphon Investors (“Gryphon”), a leading middle-market private equity firm, announced today that John Schumacher has joined the firm as a Partner to focus on multiple investment, managerial and strategic areas across the firm. More specifically, Mr. Schumacher’s responsibilities will include being a member of Gryphon’s Investment Review and Quarterly Portfolio Review Committees, co-heading Gryphon’s mezzanine funds, co-leading fundraising, and coaching various Gryphon professionals.

Mr. Schumacher has 30 years of private equity experience, having co-founded and led GoldPoint Partners LLC, a subsidiary of New York Life Insurance Company, where he presided over $7.4 billion invested in 351 direct deals and more than $15 billion in fund commitments. During his tenure, assets under management grew from $1.5 billion to over $13.6 billion. In addition, while at GoldPoint, Mr. Schumacher established a close partnership with Gryphon, providing true leadership and support as an LP Advisory Committee member and leading nine Gryphon fund investments and numerous co-investments and debt investments (in aggregate over $1 billion invested and committed) on behalf of GoldPoint and New York Life.

David Andrews, Gryphon’s Founder and CEO, said, “We are truly thrilled to welcome John as a Partner. Having worked with him extensively over the last 20 years, we developed a very close relationship over multiple PE cycles, through which my Partners and I gained a deep appreciation for John’s rare combination of strong analytical and quantitative skills with very impressive strategic and creative aptitudes. John’s proven leadership talents and personal values will be invaluable also to Gryphon as our firm continues to grow and develop.”

Mr. Schumacher earned his BA in History in 1978 from Columbia College and an MBA in 1989 from New York University’s Stern School of Business. Prior to joining New York Life in 1991 in the Private Finance Group, he was a Vice President in the Private Placement Department of Manufacturers Hanover Trust Company, where he began his career in finance. In 1999, based on the strong returns generated for New York Life in private equity, and the growing acceptance of the asset class, Mr. Schumacher co-founded GoldPoint. This created a dedicated and aligned team to manage private equity assets for both New York Life and third parties. He served as CEO of GoldPoint from inception until 2009, when he was named Chairman, responsible for overseeing all investment and business development activities and managing its fund investment business.

Mr. Schumacher commented, “I am delighted and honored to join Gryphon as a Partner. I have long respected Gryphon’s unique, integrated investment approach which combines both deal and operational expertise with repeatable processes and important cultural values that enable consistently-high investment returns with no losses of principal. I look forward to applying the leadership, strategic and investment skills I have honed over the past 30 years to contribute to the continued development of Gryphon’s team, its portfolio companies, and Gryphon itself. I believe my love for this asset class, as well as my deep respect for Gryphon, will enable me, in some small way, to add to the legacy that is Gryphon Investors.”

Nick Orum, Gryphon President and Co-founder, added, “Gryphon has benefitted for two decades from John’s global private equity perspectives, value-added investment insights, and true-partnership orientation as one of our lead LPs. We are delighted to now benefit from his comprehensive focus as our Partner, including from his extensive managerial experience and proven leadership skills.”


About Gryphon Investors
Based in San Francisco, Gryphon Investors ( is a leading private equity firm focused on profitably growing and competitively enhancing middle-market companies in partnership with experienced management. The firm has managed over $5.0 billion of equity investments and capital since 1997. Gryphon targets making equity investments of $50 million to $300 million in portfolio companies with enterprise values ranging from approximately $100 million to $600 million. Gryphon prioritizes investment opportunities where it can form strong partnerships with owners and executives to build leading companies, utilizing Gryphon’s capital, specialized professional resources, and operational expertise.


Categories: Personalia

EURAZEO strengthens its position in INFRASTRUCTURE with the arrival of a new team focused on investing in the ecological transition of the European economy

No Comments

Paris, 25 January 2021

An acknowledged pioneer in the field of sustainable development, Eurazeo today welcomes a new team dedicated to infrastructure investments within Eurazeo’s Real Assets division.

The team’s objective is to invest in sectors supporting the numerous underlying changes currently taking place in Europe, including the necessary shift to renewable, low-carbon and competitive sources of energy, as well as digital technologies in which data will help drive the economy and lead to a more efficient use of real assets.

The first fund to be raised will focus on three sectors:
• Digital infrastructure: data centers, fibre-optic networks, telecom towers, subsea cables and IoT;
• Transition infrastructure: energy storage, smart grids, smart meters, smart city infrastructure, e-mobility and clean transport infrastructure;
• Renewable energies: sustainable energy production (wind, solar, hydroelectric, geothermal, hydrogen, biomass, biogas, bioenergy), along with waste management, water/wastewater and circular economy projects.
This experienced three-person team has been working together at Marguerite for the last 10 years, and consists of:
• Laurent Chatelin, who has more than 25 years of experience in infrastructure asset financing and investment in the telecom, energy and transport sectors;
• Martin Sichelkow, who has more than 15 years of buy-side experience in infrastructure, having worked mainly in the energy sector;
• Melissa Cohen, who has more than 15 years of experience in infrastructure investment and project financing, particularly in the telecoms and transport sectors.
Together, they have invested in major projects such as FTTH networks and photovoltaic facilities in France, wind farms in Scandinavia, a motorway in Ireland and incineration plants in Eastern Europe, representing a combined enterprise value of more than €10 billion across 20+ investments.
The team will seek to raise third-party capital in order to build a balanced portfolio of sustainable infrastructure assets true to Eurazeo’s own ESG commitments and in line with the UN’s Sustainable Development Goals and the new European taxonomy regulation.

This new team will be supported by Eurazeo’s in-house expertise in adjacent investment strategies and will be able to draw on the group’s international network and ESG know-how.

Renaud Haberkorn, Managing Partner and head of Eurazeo’s Real Assets division, said:
“The creation of this team fits with Eurazeo’s ambition of making long-term investments in the sustainable infrastructure needed to develop communities, and we are looking forward to implementing our strategy of being an active, responsible investor. We are delighted to welcome Laurent, Melissa and Martin into the family. Together, we will help develop infrastructure that is resilient and compatible with decarbonisation objectives. We are confident that by integrating ESG criteria into the process of analysing, investing in and developing infrastructure assets, we will be able to achieve both positive change and strong financial returns.”

Laurent Chatelin, Partner
”We are very happy to join Eurazeo, which is known for helping companies to develop in a responsible way, and to help develop the group’s portfolio of investment strategies. With this platform, we will be able to accelerate fund raising while having the capacity to invest immediately in real assets that support the energy and digital transition across Europe.”

About Eurazeo
• Eurazeo is a leading global investment company, with a diversified portfolio of €18.8 billion in assets under management, including €13.3 billion from third parties, invested in over 430 companies. With its considerable private equity, real estate and private debt expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 300 professionals and offering in-depth sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.

• Eurazeo has offices in Paris, New York, Sao Paulo, Seoul, Shanghai, Singapore, London, Luxembourg, Frankfurt, Berlin and Madrid.
• Eurazeo is listed on Euronext Paris.
• ISIN: FR0000121121 – Bloomberg: RF FP – Reuters: EURA.PA

Tel: +33 (0)1 44 15 16 76

Tel: +33 (0)1 44 15 76 44

Tel: +44 (0) 7990 595 913

Categories: News Personalia


Trishula Therapeutics Appoints Anil Singhal as Chief Executive Officer


Trishula Continues to Advance Development of TTX-030 in collaboration with AbbVie

SOUTH SAN FRANCISCO, Calif., January 21, 2021 — Today Trishula Therapeutics, Inc., a clinical stage, privately held company developing TTX-030, a first-in-class anti-CD39 antibody in advanced cancers, announced the appointment of Anil Singhal, Ph.D., MBA, as Chief Executive Officer, effective immediately. Dr. Singhal will also serve on the Trishula Board of Directors.

“The Board of Directors of Trishula Therapeutics is thrilled to bring Anil to the company with his stellar track record in advancing novel oncology therapies from early clinical development through to approval,” said Luke Evnin, Ph.D., Chairman of Trishula’s Board of Directors. “We have complete confidence that TTX-030, our first and best-in-class anti-CD39 inhibitor, will rapidly and effectively advance under his leadership.”

“I am honored to join Trishula and collaborate with the talented and dedicated team focused on bringing TTX-030, a novel, transformational medicine, to cancer patients in great need,” said Anil Singhal. “I am excited to partner with AbbVie in advancing TTX-030 to late stages of development.”

Dr. Singhal brings to Trishula more than three decades of research and development leadership experience in the biopharmaceutical industry. He joins Trishula from Adicet Bio where, as the President and CEO, he led the company to its first oncology IND and merger with a public company. Previously, Dr. Singhal held the positions of Executive in Residence at Canaan Partners and CSO at OncoResponse Inc. Dr. Singhal also served as Vice President of Early Oncology Development at AbbVie and Head of the AbbVie Redwood City site. As a member of the R&D leadership team, he helped to build an impressive portfolio and key translational science capabilities in oncology, immunology and other diseases. Prior to his industry tenure, Dr. Singhal was Assistant Research Professor at Mount Sinai School of Medicine and Adjunct Associate Professor at University of Washington.

About Trishula

Trishula is a privately held company dedicated to the development of TTX-030, a first-in-class, anti-CD39 antibody, in collaboration with AbbVie. TTX-030 inhibits the activity of CD39, an enzyme that converts ATP to AMP, the initial steps in the generation of adenosine in the tumor microenvironment. TTX-030 prevents the formation of immune suppressive extracellular adenosine and maintains high levels of immune activating extracellular ATP, stimulating dendritic and myeloid-derived cells necessary for both innate and adaptive immunity. Currently, TTX-030 is being studied in phase 1/1b clinical trials as a monotherapy and in combination with an anti-PD-1 agent and standard chemotherapy in adults with advanced cancer (NCT03884556 and NCT04306900). For more information, please visit


Categories: Personalia

CapMan Wealth Services strengthens its wealth advisory team – recruits top professionals in Finland and Sweden


CapMan press release 21 January 2021 at 9.00 a.m. EET

CapMan Wealth Services strengthens its wealth advisory team – recruits top professionals in Finland and SwedenCapMan Wealth Services is a leading Nordic client-centric wealth advisor focusing on institutional investors, foundations, family offices and high net-worth individuals (HNWI). The company offers its clients individually tailored service and product concepts in the public and private market universe. CapMan Wealth Services has recruited four new wealth advisory, alternative investment and marketing professionals in the beginning of 2021.

Mikael Falck (CAIA, MSc. (Econ.)) joins CapMan Wealth Services as Director, Head of Private Markets and will be responsible for private market investments. His most recent employer was Swedish public pension insurance company Kåpan, where he was responsible for alternative investments, including private equity, real estate and infrastructure investments. Prior to that, he worked as Director, Portfolio Manager at Nordea Investment Management in Stockholm. Mikael has more than 15 years of experience from the private investment market.

Piia Nyberg (MSc. (Econ.)) is appointed Director, Wealth Advisory. She joins CapMan from Handelsbanken, where she worked as Investment Director and Senior Private Banker responsible for Kamppi and Ruoholahti branch office private banking clients and client acquisition.

Aaron Paulakorpi (BA) is appointed Director, Wealth Advisory. He joins CapMan from LähiTapiola, where he was responsible for private banking and ultra HNWI clients and family offices in South-Western Finland.

Pauliina Puputti (MSc. (Econ.)) is appointed Marketing and Sales Concept Specialist. She joins the team from Mandatum, where she developed and created marketing material to enhance client experience and provide sales support.

Private investments are a growing market that attracts a broadening and growing client base. CapMan Wealth Services provides also smaller institutions, foundations, family offices and high net-worth individuals with access to private equity funds and similar products that are CapMan’s core know-how. Access to the best products, investment reporting and private market expertise is combined into a unique full-service concept to clients.

“We are very pleased with our new colleagues and the experience and networks that they contribute. Our strengthened team offers a broader client base global access to publicly listed and private products,” says Christian Borgström, Managing Partner of CapMan Wealth Services.

CapMan Wealth Services is a subsidiary of CapMan Group that employs 12 professionals. The company is an investment service provider authorised by FIN-FSA.

For additional information, please contact:
Christian Borgström, Managing Partner, CapMan Wealth Services, tel. +358 40 595 5393

About CapMan
CapMan is a leading Nordic private asset expert with an active approach to value creation. We offer a wide selection of investment products and services. As one of the Nordic private equity pioneers, we have developed hundreds of companies and real estate assets and created substantial value in these businesses and assets over the past 30 years. With over €3.5 billion in assets under management, our objective is to provide attractive returns and innovative solutions to investors. We have a broad presence in the unlisted market through our local and specialised teams. Our investment strategies cover Private Equity, Real Estate and Infra. We also have a growing service business that includes procurement services, wealth management, and analysis, reporting and back office services. Altogether, CapMan employs around 150 people in Helsinki, Stockholm, Copenhagen, London and Luxembourg. We are a public company listed on Nasdaq Helsinki since 2001 and a signatory of the UN Principles for Responsible Investment (PRI) since 2012. Read more at and


Categories: Personalia

Kinnevik’s Deputy Chairman Henrik Poulsen will not be available for re-election

No Comments


20 Jan 2021, 9:30 AM

Kinnevik AB (publ) (“Kinnevik”) today announced that the Deputy Chairman of the Board of Directors, Henrik Poulsen, has informed the Nomination Committee that he will not be available for re-election at the Annual General Meeting in 2021.

The Chairman of the Nomination Committee, Anders Oscarsson, commented:

“On behalf of the shareholders I would like to thank Henrik for his dedicated work in the Kinnevik board. The nomination committee looks forward to presenting its full proposal of the new board well ahead of the Annual General Meeting.”

For further information, visit or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50

Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to make people’s lives better by providing more and better choice. In partnership with talented founders and management teams we build challenger businesses that use disruptive technology to address material, everyday consumer needs. As active owners, we believe in delivering both shareholder and social value by building long-term sustainable businesses that contribute positively to society. We invest in Europe, with a focus on the Nordics, the US, and selectively in other markets. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.


Categories: Personalia